Administration of FGF21-mimetic antibody treats diabetes and obesity FGF21 by lowering blood glucose levels and enhancing insulin sensitivity in diabetic (Foltz et al., 2012; Holland et al., 2013). The gene discussed is FGF21; the disease is Obesity.